Early research (Phase 1)Not Yet RecruitingNCT06203821What this trial is testingStudy of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic CancerWho this might be right forPancreatic Cancer Aram Hezel 25
Early research (Phase 1)UnknownNCT03703063What this trial is testingAlternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic CancerWho this might be right forPancreatic Adenocarcinoma Benaroya Research Institute 30
Testing effectiveness (Phase 2)Ended earlyNCT01688336What this trial is testingFOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic CancerWho this might be right forPancreatic Cancer UNC Lineberger Comprehensive Cancer Center 9
Early research (Phase 1)WithdrawnNCT01954732What this trial is testingMetformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by SurgeryWho this might be right forStage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic Cancer+1 more Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00795977What this trial is testingPreoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic CancerWho this might be right forPancreatic Cancer Fukushima Medical University 20
Not applicableStudy completedNCT02818907What this trial is testingEvaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially ResectableWho this might be right forPancreatic Cancer Centre Hospitalier Universitaire de Besancon 290
Early research (Phase 1)Looking for participantsNCT06756035What this trial is testingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionWho this might be right forMesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more Context Therapeutics Inc. 70
Large-scale testing (Phase 3)Looking for participantsNCT05529940What this trial is testingNeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)Who this might be right forResectable Pancreatic CancerNeoadjuvant ChemotherapyEffects of Chemotherapy Seoul National University Hospital 609
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07386704What this trial is testingNimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic CancerWho this might be right forPancreatic Cancer Non-resectable Peking University First Hospital 30
Not applicableUnknownNCT03443921What this trial is testingDivestment for Artery-involved Pancreatic CancerWho this might be right forPancreatic CancerLocally Advanced Pancreatic CancerNeoadjuvant Therapy+1 more The First Affiliated Hospital with Nanjing Medical University 122
Testing effectiveness (Phase 2)Ended earlyNCT00889187What this trial is testingNeoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic CancerWho this might be right forPancreatic Cancer Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04986930What this trial is testingMFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaPancreatic Cancer Non-resectable Asan Medical Center 92
Very early researchUnknownNCT05287165What this trial is testingClinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System NeoplasmsWho this might be right forAdvanced Solid TumorsDigestive System NeoplasmsPancreatic Cancer Resectable+1 more Beijing Immunochina Medical Science & Technology Co., Ltd. 19
Not applicableUnknownNCT02781012What this trial is testingProject Survival-Prospective Biomarker DiscoveryWho this might be right forPancreatic NeoplasmsPancreatic CancerPancreatitis+2 more Pancreatic Cancer Research Team 436
Testing effectiveness (Phase 2)Active Not RecruitingNCT05604560What this trial is testingA Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas CancerWho this might be right forPancreatic Cancer Lei Zheng 25
Very early researchWithdrawnNCT03718650What this trial is testingTotal Tumor Mapping (TTM) for Resectable Pancreatic CancerWho this might be right forPancreatic CancerResectable Pancreatic Cancer H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Not Yet RecruitingNCT07488884What this trial is testingOpen-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic CancerWho this might be right forPancreatic Cancer ResectablePancreatic Cancer ImmunityBio, Inc. 30
Not applicableLooking for participantsNCT06574620What this trial is testingUsing Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to TreatmentWho this might be right forPancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal Adenocarcinoma+1 more British Columbia Cancer Agency 200
Testing effectiveness (Phase 2)Looking for participantsNCT06538857What this trial is testingCEB-01 in Locally Resectable Pancreatic CancerWho this might be right forPancreatic Carcinoma CEBIOTEX 39
Early research (Phase 1)Study completedNCT02308722What this trial is testingSBRT Pre-operatively for Pancreatic CancerWho this might be right forPancreatic Neoplasms University of Oxford 12